BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26973841)

  • 1. Spatial Heterogeneity of Cx43 is an Arrhythmogenic Substrate of Polymorphic Ventricular Tachycardias during Compensated Cardiac Hypertrophy in Rats.
    Boulaksil M; Bierhuizen MF; Engelen MA; Stein M; Kok BJ; van Amersfoorth SC; Vos MA; van Rijen HV; de Bakker JM; van Veen TA
    Front Cardiovasc Med; 2016; 3():5. PubMed ID: 26973841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal arrhythmogenic remodelling in a mouse model of longstanding pressure overload.
    Boulaksil M; Noorman M; Engelen MA; van Veen TA; Vos MA; de Bakker JM; van Rijen HV
    Neth Heart J; 2010 Oct; 18(10):509-15. PubMed ID: 20978597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Cx43 expression triggers increased fibrosis due to enhanced fibroblast activity.
    Jansen JA; van Veen TA; de Jong S; van der Nagel R; van Stuijvenberg L; Driessen H; Labzowski R; Oefner CM; Bosch AA; Nguyen TQ; Goldschmeding R; Vos MA; de Bakker JM; van Rijen HV
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):380-90. PubMed ID: 22368123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload.
    Fontes MS; Kessler EL; van Stuijvenberg L; Brans MA; Falke LL; Kok B; Leask A; van Rijen HV; Vos MA; Goldschmeding R; van Veen TA
    J Mol Cell Cardiol; 2015 Nov; 88():82-90. PubMed ID: 26410398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow conduction and enhanced anisotropy increase the propensity for ventricular tachyarrhythmias in adult mice with induced deletion of connexin43.
    van Rijen HV; Eckardt D; Degen J; Theis M; Ott T; Willecke K; Jongsma HJ; Opthof T; de Bakker JM
    Circulation; 2004 Mar; 109(8):1048-55. PubMed ID: 14967725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular remodeling of Cx43, but not structural remodeling, promotes arrhythmias in an arrhythmogenic canine model of nonischemic heart failure.
    Yan J; Killingsworth C; Walcott G; Zhu Y; Litovsky S; Huang J; Ai X; Pogwizd SM
    J Mol Cell Cardiol; 2021 Sep; 158():72-81. PubMed ID: 34048725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced heterogeneous expression of Cx43 results in decreased Nav1.5 expression and reduced sodium current that accounts for arrhythmia vulnerability in conditional Cx43 knockout mice.
    Jansen JA; Noorman M; Musa H; Stein M; de Jong S; van der Nagel R; Hund TJ; Mohler PJ; Vos MA; van Veen TA; de Bakker JM; Delmar M; van Rijen HV
    Heart Rhythm; 2012 Apr; 9(4):600-7. PubMed ID: 22100711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of connexin43 contributes to the arrhythmogenic substrate during the development of heart failure in cardiomyopathic hamster.
    Sato T; Ohkusa T; Honjo H; Suzuki S; Yoshida MA; Ishiguro YS; Nakagawa H; Yamazaki M; Yano M; Kodama I; Matsuzaki M
    Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1164-73. PubMed ID: 18065522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy.
    Akar FG; Spragg DD; Tunin RS; Kass DA; Tomaselli GF
    Circ Res; 2004 Oct; 95(7):717-25. PubMed ID: 15345654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heavy ion radiation up-regulates Cx43 and ameliorates arrhythmogenic substrates in hearts after myocardial infarction.
    Amino M; Yoshioka K; Tanabe T; Tanaka E; Mori H; Furusawa Y; Zareba W; Yamazaki M; Nakagawa H; Honjo H; Yasui K; Kamiya K; Kodama I
    Cardiovasc Res; 2006 Dec; 72(3):412-21. PubMed ID: 17054928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connexin 43 expression and distribution in compensated and decompensated cardiac hypertrophy in patients with aortic stenosis.
    Kostin S; Dammer S; Hein S; Klovekorn WP; Bauer EP; Schaper J
    Cardiovasc Res; 2004 May; 62(2):426-36. PubMed ID: 15094362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmural dispersion of refractoriness and conduction velocity is associated with heterogeneously reduced connexin43 in a rabbit model of heart failure.
    Wiegerinck RF; van Veen TA; Belterman CN; Schumacher CA; Noorman M; de Bakker JM; Coronel R
    Heart Rhythm; 2008 Aug; 5(8):1178-85. PubMed ID: 18675229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-tracheal gene delivery of aerosolized SERCA2a to the lung suppresses ventricular arrhythmias in a model of pulmonary arterial hypertension.
    Strauss B; Sassi Y; Bueno-Beti C; Ilkan Z; Raad N; Cacheux M; Bisserier M; Turnbull IC; Kohlbrenner E; Hajjar RJ; Hadri L; Akar FG
    J Mol Cell Cardiol; 2019 Feb; 127():20-30. PubMed ID: 30502350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The experimental model of transition from compensated cardiac hypertrophy to failure created by transverse aortic constriction in mice.
    Furihata T; Kinugawa S; Takada S; Fukushima A; Takahashi M; Homma T; Masaki Y; Tsuda M; Matsumoto J; Mizushima W; Matsushima S; Yokota T; Tsutsui H
    Int J Cardiol Heart Vasc; 2016 Jun; 11():24-28. PubMed ID: 28616522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic stimulation improves electrophysiological rate adaptation during pressure overload-induced heart failure in rats.
    Zasadny FM; Dyavanapalli J; Dowling NM; Mendelowitz D; Kay MW
    Am J Physiol Heart Circ Physiol; 2020 Oct; 319(6):H1358-68. PubMed ID: 33006920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The regulatory mechanism of Raf/MEK/ERK pathway on the rat cardiac hypertrophy induced by transverse aortic constriction].
    Fu DT; Tu J; Cai YQ; Cai ZW; Zhang LZ; Liu JY; Xu SC; Wang DJ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Jan; 36(1):33-38. PubMed ID: 32476371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rho-kinase inhibition reverses impaired Ca
    Olgar Y; Celen MC; Yamasan BE; Ozturk N; Turan B; Ozdemir S
    Cell Calcium; 2017 Nov; 67():81-90. PubMed ID: 29029794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conduction remodeling in human end-stage nonischemic left ventricular cardiomyopathy.
    Glukhov AV; Fedorov VV; Kalish PW; Ravikumar VK; Lou Q; Janks D; Schuessler RB; Moazami N; Efimov IR
    Circulation; 2012 Apr; 125(15):1835-47. PubMed ID: 22412072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
    Zhou N; Ma B; Stoll S; Hays TT; Qiu H
    Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43.
    Gutstein DE; Morley GE; Tamaddon H; Vaidya D; Schneider MD; Chen J; Chien KR; Stuhlmann H; Fishman GI
    Circ Res; 2001 Feb; 88(3):333-9. PubMed ID: 11179202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.